1Grines C L, Bonow R O, Casey D E, et al. Prevention of premature discontinuation of dual antiplatelet therapy in Aatients with coronary artery stents:a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians [J]. Circulation,2007,115 ( 6 ) : 813- 818. 被引量：1
2Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding : population based case-control study [J]. BMJ, 2006, 333:726-730. 被引量：1
3Foley P,Foley S,Kinnaird T,et al. Clinical review:gastrointestinal bleeding after percutaneous coronary intervention: a deadly combination[ J ]. Q J Med ,2008, 101 (6) :425-433. 被引量：1
4Patrono C, Bachmann F, Baigent C, et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology [J]. Eur Heart J,2004,25(2) :166-181. 被引量：1
5Lai K C, Lam S K, Chu K M, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term lowdose aspirin use [ J ]. N Engl J Med, 2002, 346 ( 26 ) : 2033-2038. 被引量：1
6CAPRIE Investigators. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee [J]. Lancet, 1996, 348 (9038): 1329-1339. 被引量：1
7Eikelboom J W, Hirsh J. Bleeding and management of bleeding [J]. Eur Heart J,2006,8 ( Suppl G) : G38-45. 被引量：1
8Ng F H, Wong S Y, Chang C M, et al. High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease [ J ]. Aliment Pharmacol Ther, 2003,18(4) :443-449. 被引量：1
9Yusuf S, Zhao F, Mehta S R, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation [J]. N Engl J Med, 2001,345: 494-502. 被引量：1
10Joseph A D, Lucie O, James M B,et al. Drug-drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding[J]. CMAJ,2007,177 (4) :347-351. 被引量：1
3Bhatt DI., Scheiman J, Abraham NS. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of theAmerican College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents[J]. Circulation, 2008,52 (18) :1502-1517. 被引量：1
5Vallurupalli NG, Goldhaber SZ. Gastrointestinal complications of dual antiplatelet therapy [J]. Circulation, 2006, 113 ( 12 ) e655-e658. 被引量：1
6Bassand JP, Hamm CW, Ardissino D,et al. Guidelines for the diagnosis and treatment of non-ST-segmentelevation acute coronary syndromes[J]. Rev Port Cardiol, 2008,27 ( 9 ) : 1063-1143. 被引量：1
7Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding [J]. AnnIntern Med,2010,152(2):l0l-l13. 被引量：1
8Siriswangvat S, Sansanayudh N, Nathisuwan S, et al. Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel[J]. Circ J, 2010, 74 (10) : 2187-2192. 被引量：1
9Stoekl KM, Le L, Zakharyan A, et al. Risk of rehospitalization for patients using clopidogrel with a protonpump inhibitor[J]. Arch Intern Med, 2010,170 (8) : 704-710. 被引量：1
10Yasuda H, Yamada M, Sawada S,et al. Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting[J]. Inter Med, 2009,48(19) : 1725-1730. 被引量：1
